IL6 and prostate cancer: Prostate cancer-derived IL-6 can activate fibroblast, and then activated prostate CAFs can secrete MMPs and trigger epithelial mesenchymal transition in cancer cells to facilitate the transformation into CSCs‐like phenotype [79].